We develop a revolutionary Dermal-Delivery Technology for innovative topical-therapeutics
Cellicon Lab is a bio-venture company specializing in dermal delivery technology of topical-therapeutics. A revolutionary peptide technology, DermiShuttle, enables delivery of cargos to dermis by cell-to-cell transmission and contributes to the development of innovative therapeutics.
DermiShuttle, based on peptide, a platform biotechnology that enables delivery of cargos to dermis for topical-therapeutics. It aims to unlock the potential of topical-therapeutics that we never experienced with revolutionary delivery-effect.